ALMR Alamar Biosciences, Inc.: institutional ownership and insider trading
91 funds reported holding $664M of Alamar Biosciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $664M, with 87 new positions and 0 funds selling out; over the last 12 months insiders bought $8.00M and sold $21.0M on the open market.
Famous investors holding ALMR
- Cathie Wood (ARK Investment Management): $37.2M, 0.2% of the portfolio
- George Soros (Soros Fund Management): $1.63M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $23.5M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $4.88M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $544K, 0.0% of the portfolio
Largest institutional holders of ALMR
- Sands Capital Alternatives, LLC — $115M
- Samsara BioCapital, LLC — $67.2M
- T. Rowe Price Investment Management, Inc. — $59.7M
- ARK Investment Management LLC — $37.2M
- BRAIDWELL LP — $29.4M
- ALLIANCEBERNSTEIN L.P. — $27.2M
- HHLR ADVISORS, LTD. — $25.9M
- BlackRock, Inc. (BLK) — $24.7M
- MILLENNIUM MANAGEMENT LLC — $23.5M
- FMR LLC — $22.5M
Recent ALMR insider trades
- Oct 22, 2026: Qiming Venture Partners VI, L.P. sold 342,626 shares ($10.3M)
- Oct 20, 2026: Qiming Venture Partners VI, L.P. sold 217,512 shares ($5.95M)
- Oct 16, 2026: Qiming Venture Partners VI, L.P. sold 173,673 shares ($4.82M)
- Apr 20, 2026: Naclerio Nicholas bought 235,294 shares ($4.00M)
5%+ owners
- Qiming Corporate GP VI, Ltd: 10.2% (Schedule 13G, filed Aug 11, 2026)
- Nicholas Naclerio: 9.6% (Schedule 13D, filed Apr 23, 2026)
- Daqing Cai: 7.2% (Schedule 13G, filed Jul 2, 2026)
- Yuling Luo: 6.4% (Schedule 13G, filed Aug 13, 2026)
- Sands Capital Life Sciences Pulse Fund II, L.P.: 6.1% (Schedule 13D/A, filed Jul 7, 2026)